| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $59.2M | +15.7% |
| SG&A Expense | $29.9M | +25.5% |
| Operating Income | -$89.1M | -18.8% |
| Income Tax | $0 | — |
| Net Income | -$88.2M | -16.4% |
| EPS (Basic) | -$3.22 | +76.2% |
| EPS (Diluted) | -$3.22 | +76.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.4M | -39.2% |
| Current Assets | $124.5M | -38.5% |
| Total Assets | $139.2M | -36.2% |
| Current Liabilities | $21.1M | +65.3% |
| Total Liabilities | $33.5M | +2.7% |
| Stockholders' Equity | $105.6M | -43.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.7M | +6.2% |
| Capital Expenditures | $1.9M | +69.7% |
| Investing Cash Flow | -$1.9M | -69.7% |
| Financing Cash Flow | -$69K | -100.0% |
| Free Cash Flow | -$77.6M | +5.2% |